Eterna Therapeutics's total assets for Q were $46.49M, a decrease of -6.39% from the previous quarter. ERNA total liabilities were $55.01M for the fiscal quarter, a 3.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.